↓ Skip to main content

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

Overview of attention for article published in Gastric Cancer, September 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#17 of 647)
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs
1 blog
twitter
14 X users
facebook
2 Facebook pages

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Published in
Gastric Cancer, September 2020
DOI 10.1007/s10120-020-01116-x
Pubmed ID
Authors

Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Eva Martínez de Castro, Ana Custodio, Carles Pericay Pijaume, Raquel Hernandez, Gema Aguado, Natalia Castro Unanua, Juana María Cano, Flora López, Marcelo Garrido, Ana Fernández Montes, Laura Visa, Manuel Sánchez Cánovas, María Luisa Limón, Nieves Martínez Lago, Paola Pimentel, Alicia Hurtado, Aitor Azkárate, Federico Longo, Marc Diez, Aranzazu Arias-Martinez, Tamara Sauri, Alfonso Martín Carnicero, Monserrat Mangas, Marta Martín Richard, Mónica Granja, Avinash Ramchandani, Carolina Hernández Pérez, Paula Cerdá, Aitziber Gil-Negrete, Mariona Calvo, Rosario Vidal Tocino, Javier Gallego

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 20%
Librarian 2 20%
Lecturer > Senior Lecturer 1 10%
Student > Doctoral Student 1 10%
Other 1 10%
Other 0 0%
Unknown 3 30%
Readers by discipline Count As %
Medicine and Dentistry 3 30%
Nursing and Health Professions 1 10%
Pharmacology, Toxicology and Pharmaceutical Science 1 10%
Unknown 5 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 December 2021.
All research outputs
#2,451,352
of 25,732,188 outputs
Outputs from Gastric Cancer
#17
of 647 outputs
Outputs of similar age
#63,271
of 431,620 outputs
Outputs of similar age from Gastric Cancer
#1
of 14 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 647 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,620 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.